0001740837-24-000004.txt : 20240126
0001740837-24-000004.hdr.sgml : 20240126
20240126165752
ACCESSION NUMBER: 0001740837-24-000004
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240126
DATE AS OF CHANGE: 20240126
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-37393
FILM NUMBER: 24568717
BUSINESS ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: AltraVue Capital, LLC
CENTRAL INDEX KEY: 0001740837
ORGANIZATION NAME:
IRS NUMBER: 811081432
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 11747 NE 1ST STREET
STREET 2: SUITE 205
CITY: BELLEVUE
STATE: WA
ZIP: 98005
BUSINESS PHONE: 4254558896
MAIL ADDRESS:
STREET 1: 11747 NE 1ST STREET
STREET 2: SUITE 205
CITY: BELLEVUE
STATE: WA
ZIP: 98005
SC 13G/A
1
AVID13GFINAL01222024.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. _2__)*
AVID BIOSERVICES INC.
(Name of Issuer)
Common
(Title of Class of Securities)
05368M106
(CUSIP Number)
December 31st, 2023
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
[X] Rule 13d-1(b)
[_] Rule 13d-1(c)
[_] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a
reporting persons initial filing on this form with respect to
the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be filed for the purpose of Section 18 of
the Securities Exchange Act of 1934 (Act) or otherwise subject
to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
CUSIP No.
05368M106
1
Names of Reporting Persons
AltraVue Capital, LLC
2
Check the appropriate box if a member of a Group (see
instructions)
(a) [ ]
(b) [ ]
3
Sec Use Only
4
Citizenship or Place of Organization
Delaware, US
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5
Sole Voting Power
2,022,193
6
Shared Voting Power
952,140
7
Sole Dispositive Power
2,974,333
8
Shared Dispositive Power
0
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,974,333
10
Check box if the aggregate amount in row (9) excludes certain
shares (See Instructions)
[ ]
11
Percent of class represented by amount in row (9)
4.70%
12
Type of Reporting Person (See Instructions)
IA
Item 1.
(a) Name of Issuer: Avid Bioservices Inc.
(b) Address of Issuer's Principal Executive Offices:
14191 Myford Road
Tustin, CA 92780
Item 2.
(a) Name of Person Filing: AltraVue Capital, LLC
(b) Address of Principal Business Office or, if None, Residence:
11747 NE 1st Street, Suite 205
Bellevue, WA 98005-3018
(c) Citizenship: USA
(d) Title and Class of Securities: Common
(e) CUSIP No.: 05368M106
Item 3. If this statement is filed pursuant to 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is
a:
(a) [_] Broker or dealer registered under Section 15 of
the Act;
(b) [_] Bank as defined in Section 3(a)(6) of the Act;
(c) [_] Insurance company as defined in Section 3(a)(19)
of the Act;
(d) [_] Investment company registered under Section 8 of
the Investment Company Act of 1940;
(e) X An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in
accordance with Rule 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in
accordance with Rule 13d-1(b)(1)(ii)(G);
(h) [_] A savings associations as defined in Section 3(b)
of the Federal Deposit Insurance Act (12 U.S.C.
1813);
(i) [_] A church plan that is excluded from the
definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940;
(j) [_] A non-U.S. institution in accordance with Rule
240.13d-1(b)(1)(ii)(J);
(k) [_] Group, in accordance with Rule 240.13d-
1(b)(1)(ii)(K). If filing as a non-U.S.
institution in accordance with Rule 240.13d-
1(b)(1)(ii)(J), please specify the type of
institution: ____
Item 4. Ownership
(a) Amount Beneficially Owned: 2,974,333
(b) Percent of Class: 4.70%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 2,022,193
(ii) Shared power to vote or to direct the vote: 952,140
0
(iii) Sole power to dispose or to direct the disposition 2,974,333
of: 0
(iv) Shared power to dispose or to direct the disposition
of: 0
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be
the beneficial owner of more than five percent of the class
of securities, check the following [ X ].
Item 6. Ownership of more than Five Percent on Behalf of Another
Person.
Item 7. Identification and classification of the subsidiary which
acquired the security being reported on by the parent
holding company or control person.
Item 8. Identification and classification of members of the
group.
Item 9. Notice of Dissolution of Group.
Item 10. Certifications.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete, and correct.
Dated: January 23th, 2024
/s/ Signature
Tom Parkhurst / COO & CCO
Name/Title
The original statement shall be signed by each person on whose
behalf the statement is filed or his authorized representative.
If the statement is signed on behalf of a person by his
authorized representative (other than an executive officer or
general partner of this filing person), evidence of the
representatives authority to sign on behalf of such person shall
be filed with the statement, provided, however, that a power of
attorney for this purpose which is already on file with the
Commission may be incorporated by reference. The name and any
title of each person who signs the statement shall be typed or
printed beneath his signature.
Attention: Intentional misstatements or omissions of fact
constitute Federal criminal violations (See 18 U.S.C. 1001).
Page 1 of 1